Microsoft sued by Australia competition regulator over Copilot, 365 pricing
Investing.com - Sidoti downgraded Plexus (NASDAQ:PLXS), a $4 billion market cap electronics manufacturing services provider, from Buy to Neutral on Friday, maintaining a price target of $150.00 following the company’s fourth-quarter fiscal 2025 results. According to InvestingPro data, the stock is currently trading near its Fair Value, with a perfect Piotroski Score of 9, indicating strong financial health.
The research firm described Plexus’s quarterly performance as "solid," noting that weaknesses in certain areas were offset by strengths elsewhere, supported by the company’s diversified portfolio.
Sidoti reduced its fiscal 2026 and 2027 estimates for Plexus, citing caution due to an uncertain macroeconomic environment and management commentary during the earnings report.
The fourth-quarter fiscal 2025 revenue and margins met expectations, while earnings per share outperformed due to a one-time tax benefit, according to Sidoti’s analysis.
Despite cautious outlook on revenue growth for the next two fiscal years, Sidoti expects Plexus will continue controlling expenses, with earnings per share benefiting from lower interest expenses and reduced share count, supported by positive cash generation.
In other recent news, Plexus Corp. reported its fourth-quarter 2025 earnings, achieving an earnings per share (EPS) of $2.14, which exceeded analysts’ forecasts of $1.87 by 14.44%. The company’s revenue came in at $1.058 billion, meeting market expectations and aligning with its own guidance. These results indicate a strong performance in the latest quarter. Despite the earnings beat, the market reaction was muted, with the stock closing at $146.1, a slight decrease. Analysts from various firms have closely monitored these developments, though no upgrades or downgrades were noted in the latest reports. Investors might find these earnings results encouraging as they reflect the company’s ability to outperform expectations. These are the latest updates concerning Plexus Corp., reflecting its financial health and market position.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.